{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:16:32Z","timestamp":1790741792494,"version":"4.1.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":1919,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Most U.S. residents who develop tuberculosis (TB) were born abroad, and U.S. TB incidence is increasingly driven by infection risks in other countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the potential impact of effective global TB control on health and economic outcomes in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We estimated outcomes using linked mathematical models of TB epidemiology in the United States and migrants\u2019 birth countries. A base-case scenario extrapolated country-specific TB incidence trends. We compared this with scenarios in which countries achieve 90% TB incidence reductions between 2015 and 2035, as targeted by the World Health Organization\u2019s End TB Strategy (\u201ceffective global TB control\u201d). We also considered pessimistic scenarios of flat TB incidence trends in individual countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>We estimated TB cases, deaths, and costs and the total economic burden of TB in the United States. Compared with the base-case scenario, effective global TB control would avert 40,000 (95% uncertainty interval, 29,000\u201355,000) TB cases in the United States in 2020\u20132035. TB incidence rates in 2035 would be 43% (95% uncertainty interval, 34\u201354%) lower than in the base-case scenario, and 49% (95% uncertainty interval, 44\u201355%) lower than in 2020. Summed over 2020\u20132035, this represents 0.8 billion dollars (95% uncertainty interval, 0.6\u20131.0 billion dollars) in averted healthcare costs and $2.5 billion dollars (95% uncertainty interval, 1.7\u20133.6 billion dollars) in productivity gains. The total U.S. economic burden of TB (including the value of averted TB deaths) would be 21% (95% uncertainty interval, 16\u201328%) lower (18 billion dollars [95% uncertainty level, 8\u201332 billion dollars]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In addition to producing major health benefits for high-burden countries, strengthened efforts to achieve effective global TB control could produce substantial health and economic benefits for the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.202003-0526oc","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T18:04:04Z","timestamp":1594317844000},"page":"1567-1575","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":23,"title":["Impact of Effective Global Tuberculosis Control on Health and Economic Outcomes in the United States"],"prefix":"10.1093","volume":"202","author":[{"given":"Nicolas A.","family":"Menzies","sequence":"first","affiliation":[{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Bellerose","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Testa","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Swartwood","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelena","family":"Malyuta","sequence":"additional","affiliation":[{"name":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"Marks","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew N.","family":"Hill","sequence":"additional","affiliation":[{"name":"Division of Tuberculosis Elimination"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand A.","family":"Date","sequence":"additional","affiliation":[{"name":"Division of Global HIV and Tuberculosis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan A.","family":"Maloney","sequence":"additional","affiliation":[{"name":"Division of Global HIV and Tuberculosis, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Bowden","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardath W.","family":"Grills","sequence":"additional","affiliation":[{"name":"Division of Global Migration and Quarantine, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Salomon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Stanford University, Palo Alto, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2026030321514957900_bib1","volume-title":"Global tuberculosis report.","author":"World Health Organization","year":"2018"},{"key":"2026030321514957900_bib2","first-page":"490","article-title":"Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts","volume":"85","author":"Ferebee","year":"1962","journal-title":"Am Rev Respir Dis"},{"key":"2026030321514957900_bib3","article-title":"The ten-year incidence of clinical tuberculosis following \u201cconversion\u201d in 2550 individuals aged 14 to 19 years","volume-title":"TSRU Progress Report","author":"Sutherland","year":"1968"},{"key":"2026030321514957900_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.15585\/mmwr.mm6511a2","article-title":"Leveling of tuberculosis incidence - United States, 2013-2015","volume":"65","author":"Salinas","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030321514957900_bib5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.15585\/mmwr.mm6811a2","article-title":"Tuberculosis: United States, 2018","volume":"68","author":"Talwar","year":"2019","journal-title":"Morb Mortal Wkly Rep"},{"key":"2026030321514957900_bib6","volume-title":"Reported tuberculosis in the United States.","author":"US Centers for Disease Control and Prevention","year":"2018"},{"key":"2026030321514957900_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1164\/rccm.201907-1289OC","article-title":"Comparative modeling of tuberculosis epidemiology and policy outcomes in California","volume":"201","author":"Menzies","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321514957900_bib8","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201702-0377OC","article-title":"Comparing drivers and dynamics of tuberculosis in California, Florida, New York, and Texas","volume":"196","author":"Shrestha","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026030321514957900_bib9","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/aje\/kwy094","article-title":"Prospects for tuberculosis elimination in the United States: results of a transmission dynamic model","volume":"187","author":"Menzies","year":"2018","journal-title":"Am J Epidemiol"},{"key":"2026030321514957900_bib10","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/aje\/kwv121","article-title":"A field-validated approach using surveillance and genotyping data to estimate tuberculosis attributable to recent transmission in the United States","volume":"182","author":"France","year":"2015","journal-title":"Am J Epidemiol"},{"key":"2026030321514957900_bib11","doi-asserted-by":"crossref","first-page":"e0153728","DOI":"10.1371\/journal.pone.0153728","article-title":"Recent transmission of tuberculosis - United States, 2011-2014","volume":"11","author":"Yuen","year":"2016","journal-title":"PLoS One"},{"key":"2026030321514957900_bib12","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2016.11046","article-title":"Screening for latent tuberculosis infection in adults: US Preventive Services Task Force Recommendation Statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"2026030321514957900_bib13","volume-title":"Latent tuberculosis infection: a guide for primary health care providers.","author":"US Centers for Disease Control and Prevention","year":"2013"},{"key":"2026030321514957900_bib14","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1183\/13993003.01245-2015","article-title":"Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries","volume":"46","author":"Getahun","year":"2015","journal-title":"Eur Respir J"},{"key":"2026030321514957900_bib15","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1017\/S095026881100286X","article-title":"Modelling tuberculosis trends in the USA","volume":"140","author":"Hill","year":"2012","journal-title":"Epidemiol Infect"},{"key":"2026030321514957900_bib16","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJMsa043194","article-title":"Domestic returns from investment in the control of tuberculosis in other countries","volume":"353","author":"Schwartzman","year":"2005","journal-title":"N Engl J Med"},{"key":"2026030321514957900_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1186\/s12889-015-2530-7","article-title":"A cost-benefit analysis of a proposed overseas refugee latent tuberculosis infection screening and treatment program","volume":"15","author":"Wingate","year":"2015","journal-title":"BMC Public Health"},{"key":"2026030321514957900_bib18","doi-asserted-by":"crossref","first-page":"e0124116","DOI":"10.1371\/journal.pone.0124116","article-title":"Cost-effectiveness of screening and treating foreign-born students for tuberculosis before entering the United States","volume":"10","author":"Wingate","year":"2015","journal-title":"PLoS One"},{"key":"2026030321514957900_bib19","article-title":"2017 American Community Survey 1-year estimates (S0501 selected characteristics of the native and foreign-born populations)","author":"US Census Bureau","year":"2019"},{"key":"2026030321514957900_bib20","volume-title":"The End TB Strategy.","author":"World Health Organization","year":"2016"},{"key":"2026030321514957900_bib21","article-title":"2017 state and city tuberculosis indicators report","author":"US Centers for Disease Control and Prevention","year":"2018"},{"key":"2026030321514957900_bib22","article-title":"World population prospects: the 2017 revision","author":"United Nations Population Division","year":"2017"},{"key":"2026030321514957900_bib23","article-title":"WHO global TB database","author":"WHO Global TB Programme","year":"2019"},{"key":"2026030321514957900_bib24","doi-asserted-by":"crossref","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"2026030321514957900_bib25","article-title":"Integrated public use microdata series: American Community Survey","author":"Ruggles","year":"2015"},{"key":"2026030321514957900_bib26","article-title":"Methodology, assumptions, and inputs for the 2017 National Population Projections","author":"US Census Bureau","year":"2018"},{"key":"2026030321514957900_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/13696998.2018.1542520","article-title":"Estimated annual and lifetime labor productivity in the United States, 2016: implications for economic evaluations","volume":"22","author":"Grosse","year":"2019","journal-title":"J Med Econ"},{"key":"2026030321514957900_bib28","volume-title":"Guidelines for regulatory impact analysis.","author":"Robinson","year":"2016"},{"key":"2026030321514957900_bib29","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/hec.3214","article-title":"Valuing reductions in fatal illness risks: implications of recent research","volume":"25","author":"Robinson","year":"2016","journal-title":"Health Econ"},{"key":"2026030321514957900_bib30","volume-title":"R: a language and environment for statistical computing.","author":"R Core Team","year":"2018"},{"key":"2026030321514957900_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i08","article-title":"Rcpp: seamless R and C++ integration","volume":"40","author":"Eddelbuettel","year":"2011","journal-title":"J Stat Softw"},{"key":"2026030321514957900_bib32","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s40273-017-0494-4","article-title":"Bayesian methods for calibrating health policy models: a tutorial","volume":"35","author":"Menzies","year":"2017","journal-title":"Pharmacoeconomics"},{"key":"2026030321514957900_bib33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0272989X12458348","article-title":"Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6","volume":"32","author":"Briggs","year":"2012","journal-title":"Med Decis Making"},{"key":"2026030321514957900_bib34","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1541-0420.2010.01399.x","article-title":"Estimating and projecting trends in HIV\/AIDS generalized epidemics using Incremental Mixture Importance Sampling","volume":"66","author":"Raftery","year":"2010","journal-title":"Biometrics"},{"key":"2026030321514957900_bib35","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.5588\/ijtld.17.0185","article-title":"The impact of migration on tuberculosis in the United States","volume":"22","author":"Menzies","year":"2018","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321514957900_bib36","doi-asserted-by":"crossref","first-page":"e65276","DOI":"10.1371\/journal.pone.0065276","article-title":"Predicting U.S. tuberculosis case counts through 2020","volume":"8","author":"Woodruff","year":"2013","journal-title":"PLoS One"},{"key":"2026030321514957900_bib37","doi-asserted-by":"crossref","first-page":"e816","DOI":"10.1016\/S2214-109X(16)30265-0","article-title":"Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models","volume":"4","author":"Menzies","year":"2016","journal-title":"Lancet Glob Health"},{"key":"2026030321514957900_bib38","article-title":"The paradigm shift 2016-2020, global plan to end TB: Annex 6, estimating the cost of the 90-(90)-90 strategy","author":"Stop TB Partnership and UNOPS","year":"2015"},{"key":"2026030321514957900_bib39","article-title":"Post-2015 Global TB Strategy and targets (A67\/62)","author":"World Health Assembly","year":"2014"},{"key":"2026030321514957900_bib40","doi-asserted-by":"crossref","first-page":"e001135","DOI":"10.1136\/bmjgh-2018-001135","article-title":"Tuberculosis preventive treatment: the next chapter of tuberculosis elimination in India","volume":"3","author":"Moonan","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2026030321514957900_bib41","volume-title":"Guidance for country-level TB modelling.","author":"WHO Global TB Programme & TB Modelling and Analysis Consortium","year":"2018"},{"key":"2026030321514957900_bib42","doi-asserted-by":"crossref","first-page":"926","DOI":"10.5588\/ijtld.15.1001","article-title":"Estimating tuberculosis cases and their economic costs averted in the United States over the past two decades","volume":"20","author":"Castro","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2026030321514957900_bib43","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1056\/NEJMoa0809497","article-title":"Overseas screening for tuberculosis in U.S.-bound immigrants and refugees","volume":"360","author":"Liu","year":"2009","journal-title":"N Engl J Med"},{"key":"2026030321514957900_bib44","first-page":"234","article-title":"Implementation of new TB screening requirements for U.S.-bound immigrants and refugees - 2007-2014","volume":"63","author":"Posey","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026030321514957900_bib45","doi-asserted-by":"crossref","first-page":"e32158","DOI":"10.1371\/journal.pone.0032158","article-title":"Estimating the impact of newly arrived foreign-born persons on tuberculosis in the United States","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"2026030321514957900_bib46","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1164\/rccm.201809-1623ED","article-title":"Tuberculosis elimination, research, and respect for persons","volume":"199","author":"Schluger","year":"2019","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/11\/1567\/67176321\/ajrccm_202_11_1567.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/202\/11\/1567\/67176321\/ajrccm_202_11_1567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:52:04Z","timestamp":1772592724000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/202\/11\/1567\/8495386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.202003-0526oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-03-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}